<DOC>
	<DOCNO>NCT01097720</DOCNO>
	<brief_summary>This study investigate neurodevelopmental effect prenatal exposure lamotrigine ( LTG ) , sodium valproate ( VPA ) , carbamazepine ( CBZ ) monotherapies . The hypothesis test include : 1 . Exposure pregnancy CBZ , LTG , VPA , monotherapy , associate developmental delay without sign autism . 2 . Exposure drug ( CBZ , LTG , VPA ) monotherapy associate increased rate occurrence major malformation . 3 . The child major malformation likely developmental delay without sign autism child major malformation . 4 . The occurrence adaptive behavior outcome show dose-response relationship dose medication take mother first trimester . The study population include child 36-83 month age expose throughout gestation one three drug interest , treatment maternal seizure disorder .</brief_summary>
	<brief_title>Developmental Delay Children Exposed During Pregnancy Either Lamotrigine , Sodium Valproate , Carbamazepine</brief_title>
	<detailed_description />
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>3683 month age Prenatal exposure LTG , VPA , CBZ monotherapy AED use mother suppress seizure Mother enrol North American AED Pregnancy Registry Exposure first trimester know teratogen . Mother mental health issue Refusal release medical record confirm eligibility .</criteria>
	<gender>All</gender>
	<minimum_age>36 Months</minimum_age>
	<maximum_age>83 Months</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Valproate</keyword>
	<keyword>Lamotrigine</keyword>
	<keyword>Carbamazepine</keyword>
	<keyword>Anticonvulsant</keyword>
	<keyword>Antiepileptic</keyword>
	<keyword>Teratogen</keyword>
	<keyword>Autism</keyword>
	<keyword>Developmental Delay</keyword>
</DOC>